Overview

Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric Cancer

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Investigators assessed the effectiveness of Nab-paclitaxel combined with S-1 treating diffuse type of stage Ⅲ gastric cancer as adjuvant setting
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel